CA1124176A - Antitumor agent - Google Patents

Antitumor agent

Info

Publication number
CA1124176A
CA1124176A CA346,374A CA346374A CA1124176A CA 1124176 A CA1124176 A CA 1124176A CA 346374 A CA346374 A CA 346374A CA 1124176 A CA1124176 A CA 1124176A
Authority
CA
Canada
Prior art keywords
cells
yit
mouse
negative
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA346,374A
Other languages
English (en)
French (fr)
Inventor
Seizaburo Kobayashi
Teruo Yokokura
Ikuo Kato
Masahiko Mutai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of CA1124176A publication Critical patent/CA1124176A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA346,374A 1979-02-27 1980-02-25 Antitumor agent Expired CA1124176A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent
JP21339/1979 1979-02-27

Publications (1)

Publication Number Publication Date
CA1124176A true CA1124176A (en) 1982-05-25

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
CA346,374A Expired CA1124176A (en) 1979-02-27 1980-02-25 Antitumor agent

Country Status (12)

Country Link
US (1) US4347240A (cg-RX-API-DMAC7.html)
JP (1) JPS55113718A (cg-RX-API-DMAC7.html)
BR (1) BR8001129A (cg-RX-API-DMAC7.html)
CA (1) CA1124176A (cg-RX-API-DMAC7.html)
CH (1) CH653556A5 (cg-RX-API-DMAC7.html)
DE (1) DE3007412A1 (cg-RX-API-DMAC7.html)
FR (1) FR2450108B1 (cg-RX-API-DMAC7.html)
HK (1) HK23784A (cg-RX-API-DMAC7.html)
IT (1) IT1129802B (cg-RX-API-DMAC7.html)
MY (1) MY8500010A (cg-RX-API-DMAC7.html)
NL (1) NL189999C (cg-RX-API-DMAC7.html)
SG (1) SG38183G (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) * 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus casei subsp casei 37 de production d'une preparation biologique bacterienne
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
EP0974666A4 (en) 1996-06-26 2004-12-15 Yakult Honsha Kk METHODS OF GENTRANSFER IN CHROMOSOMES
JP4743925B2 (ja) * 1997-02-11 2011-08-10 エンタープライズ アイルランド トレーディング アズ バイオリサーチ アイルランド ラクトバシラス・サリバリウス由来の生体に有益な菌株及びそれより得られた抗菌剤
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
DE69832267T2 (de) * 1997-04-18 2006-08-10 Ganeden Biotech, Inc., La Jolla Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
ES2425221T3 (es) * 2003-05-30 2013-10-14 Amylin Pharmaceuticals, Llc Nuevos métodos y composiciones para suministro por vía transmucosa potenciado de péptidos y proteínas
US7863033B2 (en) * 2003-07-30 2011-01-04 Bhph Company Limited Lactobacillus living body activating Lactobacillus preparation and preventive or therapeutic agent for living body infection
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
DK1853284T3 (da) * 2005-02-11 2014-07-14 Biolactis Inc Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum
US8404823B2 (en) * 2006-10-27 2013-03-26 Kabushiki Kaisha Yakult Honsha Cytokine production regulator gene and use thereof
US20100068184A1 (en) * 2006-11-02 2010-03-18 Aureo Co., Ltd. Living body healing accelerator
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
WO2011058535A1 (en) 2009-11-11 2011-05-19 Alimentary Health Limited Probiotic bifidobacterium strain
WO2011058536A1 (en) 2009-11-11 2011-05-19 Alimentary Health Limited A bifidobacterium strain
EP3589726A1 (en) 2017-02-28 2020-01-08 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
CA3092728A1 (en) 2017-03-23 2018-09-27 Universiteit Antwerpen A novel probiotic lactobacillus casei strain and its uses
WO2021180973A1 (en) 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Also Published As

Publication number Publication date
JPS55113718A (en) 1980-09-02
CH653556A5 (de) 1986-01-15
US4347240A (en) 1982-08-31
FR2450108A1 (fr) 1980-09-26
DE3007412A1 (de) 1980-11-06
NL189999C (nl) 1993-10-01
IT8067302A0 (it) 1980-02-27
HK23784A (en) 1984-03-23
JPS6234727B2 (cg-RX-API-DMAC7.html) 1987-07-28
SG38183G (en) 1984-07-20
IT1129802B (it) 1986-06-11
NL189999B (nl) 1993-05-03
MY8500010A (en) 1985-12-31
BR8001129A (pt) 1980-11-04
FR2450108B1 (fr) 1988-10-28
NL8001045A (nl) 1980-08-29

Similar Documents

Publication Publication Date Title
CA1124176A (en) Antitumor agent
US4710379A (en) Intestinal microflora-improving agent
US4746512A (en) Anticariogenic or antiperiodontitic agent
JP2572937B2 (ja) 新規菌株
EP0228861B1 (en) Agent for reducing the dimethylnitrosoamine level
Ishihara et al. Growth inhibition of Streptococcus mutans by cellular extracts of human intestinal lactic acid bacteria
KR870001373B1 (ko) 항생물질 BMG 162-aF2의 제조방법
CN113773978A (zh) 青春双歧杆菌及其应用
US5484715A (en) Method for preparing an antitumor dextran using a dextran synthetase from Lactobacillus confusus
US5601999A (en) Antitumor polysaccharide-glycan complexes
GB2072502A (en) Antitumour agent comprising lactobacillus casei
US3936354A (en) Anti-tumour product of bacterial origin
EP0406087B1 (en) Antihypertensives and food and drinks containing such antihypertensives
US6342366B1 (en) Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microorganisms and a method for inducing and keeping said activity in lactobacilli cultures
US5565342A (en) Process for producing polysaccharide ron substance with a synthetase
CA1286623C (en) Liver function-improving agent and blood pressure- lowering agent
JPS6011686B2 (ja) 新規な抗腫瘍剤
CA1276897C (en) Hypocholesterolemically active rna fractions
CA1135184A (en) Anti-tumor preparation and process for preparing the same
US4833129A (en) Hypocholesterolemically and/or hypotriglyceridemically active RNA fractions
KR970009149B1 (ko) Wf 2015 a 및 b화합물 및 그 제조 방법
JPH0696601B2 (ja) 新規な多糖物質ｌｋ−１００及びその製造法並びに抗腫瘍剤
KR100398063B1 (ko) 내산성 및 내담즙산성이 우수한 비피도박테리아 롱검ｂｏ-11과 이의 이용
CA1063048A (en) Anti-tumor product from clostridium perfringens
JPS5915634B2 (ja) 発酵法によるアクチノマイシンの製造法

Legal Events

Date Code Title Description
MKEX Expiry